00:00 / 00:00
Apnea of prematurity
Acute respiratory distress syndrome
Pulmonary changes at high altitude and altitude sickness
Congenital pulmonary airway malformation
Superior vena cava syndrome
Meconium aspiration syndrome
Neonatal respiratory distress syndrome
Sudden infant death syndrome
Transient tachypnea of the newborn
Alpha 1-antitrypsin deficiency
Idiopathic pulmonary fibrosis
Restrictive lung diseases
Retropharyngeal and peritonsillar abscesses
Upper respiratory tract infection
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Cystic fibrosis: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Lung cancer and mesothelioma: Pathology review
Obstructive lung diseases: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Pneumonia: Pathology review
Respiratory distress syndrome: Pathology review
Restrictive lung diseases: Pathology review
Tuberculosis: Pathology review
0 / 8 complete
0 / 2 complete
Cal - Stem Cell Patient - Successful stem cell therapy for Pulmonary Hypertension
Pulmonary Hypertension Classification (WHO)
Pulmonary Hypertension Diagnosis and Management
pulmonary arterial hypertension p. 699
pulmonary hypertension p. 699
pulmonary hypertension p. 686
pulmonary hypertension p. 707
for pulmonary hypertension p. 707
high altitude and p. 688
cor pulmonale p. 686
drug therapy p. 707
PDE-5 inhibitors for p. 677
Schistosoma p. , 157
sleep apnea p. 699
Pulmonary hypertension refers to increased blood pressure in the pulmonary circulation, more specifically a mean pulmonary arterial pressure that is greater than 25 mmHg.
The pulmonary circulation starts with the right ventricle.
From there - blood is pumped into the large pulmonary trunk, which splits to form the two pulmonary arteries – one for each lung.
The pulmonary arteries divide into smaller arteries known as pulmonary arterioles and then eventually into pulmonary capillaries which surround the alveoli - which are the millions of tiny air sacs where gas exchange happens.
At that point, oxygen enters the blood and carbon dioxide enters the alveoli.
The pulmonary capillaries drain into small veins that join to form the two pulmonary veins exiting each lung, and these pulmonary veins complete the circuit by delivering oxygen-rich blood into the left atrium.
The blood pressure in the pulmonary circulation is normally much lower than the systemic blood pressure.
The normal pulmonary artery pressure is about 25/10 mmHg with a mean arterial pressure of 15 mmHg.
Pulmonary hypertension most commonly develops as a result of left heart disease.
Pulmonary hypertension (PH) is a condition characterized by an increase in blood pressure in the pulmonary artery, pulmonary vein, or pulmonary capillaries. It can be due to left heart disease, chronic lung disease, or other conditions that specifically cause pulmonary arterial hypertension. Regardless of the cause, it can complicate right-sided heart failure, what's referred to as cor pulmonale. Symptoms of PH include shortness of breath, dizziness, fainting, and leg swelling. Treatment focuses on the underlying cause and may include supplemental oxygen, and medications like endothelin receptor antagonists and prostacyclins.
Latest on COVID-19
Nurse Practitioner (NP)
Physician Assistant (PA)
Create custom content
Raise the Line Podcast
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
Terms and Conditions
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.